Who Supplies Glimepiride? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Glimepiride exports, with 242+ registered manufacturers shipping to buyers across 94+ countries — yet a handful of companies dominate the shipments. INDOCO REMEDIES LIMITED holds the largest share at 60.4% (export value: $46.0M). Close behind, IPCA LABORATORIES LIMITED (4.2%, $3.2M). MICRO LABS LIMITED (4.0%, $3.1M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Glimepiride? Top Manufacturers & Their Buyers
Flow of Glimepiride from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Glimepiride Supplier Network — Key Market Intelligence
The Glimepiride export market from India is led by INDOCO REMEDIES LIMITED, which alone commands a 60.4% share, shipping $46.0M worth of product across 41 shipments. The second-largest exporter, IPCA LABORATORIES LIMITED, contributes $3.2M (4.2%) to the overall market. Combined, the top two suppliers alone account for 64.6% of all Glimepiride exports, indicating a relatively concentrated supply base.
Across all 242 tracked manufacturers, the total Glimepiride export value stands at $76.3M from 3.2K shipments. The market average shipment value is $24.2K. The single largest buyer relationship in terms of trade value is EVERSANA LIFE SCIENCE SERVICES LLC, receiving $939.5K worth of product.
The combined buyer network spans 14 named purchasing companies, including MSJ LIMITED (UNICORN, R.A. WILLIAMS DISTRI, R A WILLIAMS DISTRIB, MASSY DISTRIBUTION (, EVERSANA LIFE SCIENCE SERVICES LLC and 9 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1INDOCO REMEDIES LIMITED
INDOCO REMEDIES LIMITED is the first-largest Glimepiride exporter from India, with a market share of 60.4% and a total export value of $46.0M across 41 shipments. Their average shipment value of $1.1M is above the market average of $24.2K, suggesting premium or bulk contract pricing.
INDOCO REMEDIES LIMITED serves 1 named buyer in our database. NA is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• NA — $46.0M across 41 shipments (100.0% of this supplier's total exports)
Key Insight: INDOCO REMEDIES LIMITED's per-shipment value of $1.1M is 4550% above the market average of $24.2K, consistent with large-order contracts or value-added formulations.
2IPCA LABORATORIES LIMITED
IPCA LABORATORIES LIMITED is the second-largest Glimepiride exporter from India, with a market share of 4.2% and a total export value of $3.2M across 90 shipments. Their average shipment value of $36.0K is above the market average of $24.2K, suggesting premium or bulk contract pricing.
IPCA LABORATORIES LIMITED serves 5 named buyers in our database. NA is the dominant customer, accounting for 84.3% of this supplier's tracked business. Top customers include:
• NA — $2.7M across 76 shipments (84.3% of this supplier's total exports)
• MSJ LIMITED (UNICORN — $201.2K across 6 shipments (6.2% of this supplier's total exports)
• R.A. WILLIAMS DISTRI — $148.6K across 4 shipments (4.6% of this supplier's total exports)
• R A WILLIAMS DISTRIB — $89.4K across 2 shipments (2.8% of this supplier's total exports)
• MASSY DISTRIBUTION ( — $70.9K across 2 shipments (2.2% of this supplier's total exports)
Key Insight: IPCA LABORATORIES LIMITED's per-shipment value of $36.0K is 49% above the market average of $24.2K, consistent with large-order contracts or value-added formulations.
3MICRO LABS LIMITED
MICRO LABS LIMITED is the third-largest Glimepiride exporter from India, with a market share of 4.0% and a total export value of $3.1M across 439 shipments. Their average shipment value of $7.0K is below the market average of $24.2K, reflecting a high-volume, competitive pricing strategy.
MICRO LABS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• EVERSANA LIFE SCIENCE SERVICES LLC — $939.5K across 135 shipments (30.7% of this supplier's total exports)
• AMERISOURCE HEALTH SERVICES — $704.6K across 101 shipments (23.0% of this supplier's total exports)
• EVERSANA LIFE SCIENCE SERVICES LLC — $672.5K across 97 shipments (22.0% of this supplier's total exports)
• BROWN AND BURK PHILIPPINES INC — $428.9K across 62 shipments (14.0% of this supplier's total exports)
• EVERSANA LIFE SCIENCE SERVICES LLC — $312.0K across 45 shipments (10.2% of this supplier's total exports)
Key Insight: MICRO LABS LIMITED operates with high shipment frequency (439 shipments) at a per-shipment value of $7.0K, indicating a broad distribution network with many smaller, regular orders.
4MEDREICH LIMITED
MEDREICH LIMITED is the fourth-largest Glimepiride exporter from India, with a market share of 2.3% and a total export value of $1.8M across 42 shipments. Their average shipment value of $42.6K is above the market average of $24.2K, suggesting premium or bulk contract pricing.
MEDREICH LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• MEIJI SEIKA PHARMATECH CO LIMITED — $818.7K across 19 shipments (45.7% of this supplier's total exports)
• MEIJI SEIKA PHARMATECH CO LIMITED — $629.2K across 15 shipments (35.1% of this supplier's total exports)
• MEIJI SEIKA PHARMATECH CO LIMITED — $170.6K across 4 shipments (9.5% of this supplier's total exports)
• MEIJI SEIKA PHARMATECH CO LIMITED — $110.6K across 3 shipments (6.2% of this supplier's total exports)
• MEIJI SEIKA PHARMA C — $61.4K across 1 shipments (3.4% of this supplier's total exports)
Key Insight: MEDREICH LIMITED's per-shipment value of $42.6K is 77% above the market average of $24.2K, consistent with large-order contracts or value-added formulations.
5INVENTIA HEALTHCARE LIMITED
INVENTIA HEALTHCARE LIMITED is the fifth-largest Glimepiride exporter from India, with a market share of 2.1% and a total export value of $1.6M across 108 shipments. Their average shipment value of $14.6K is below the market average of $24.2K, reflecting a high-volume, competitive pricing strategy.
INVENTIA HEALTHCARE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• MAXXCARE COMPANY LIMITED. — $476.0K across 33 shipments (30.3% of this supplier's total exports)
• MAXXCARE COMPANY LIMITED. — $405.9K across 28 shipments (25.8% of this supplier's total exports)
• I.E. MEDICA INC. — $261.1K across 18 shipments (16.6% of this supplier's total exports)
• HEALOL PHARMACEUTICALS SDN. BHD., — $218.4K across 15 shipments (13.9% of this supplier's total exports)
• I.E. MEDICA INC. — $211.0K across 14 shipments (13.4% of this supplier's total exports)
Key Insight: INVENTIA HEALTHCARE LIMITED operates with high shipment frequency (108 shipments) at a per-shipment value of $14.6K, indicating a broad distribution network with many smaller, regular orders.
6SUN PHARMACEUTICAL INDUSTRIES LIMITED
SUN PHARMACEUTICAL INDUSTRIES LIMITED is the fifth-largest Glimepiride exporter from India, with a market share of 1.2% and a total export value of $908.8K across 66 shipments. Their average shipment value of $13.8K is below the market average of $24.2K, reflecting a high-volume, competitive pricing strategy.
SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• I AND M BANK (T) LTD — $247.5K across 18 shipments (27.2% of this supplier's total exports)
• MYIT MAHAR TRADING C — $239.1K across 17 shipments (26.3% of this supplier's total exports)
• NA — $196.1K across 14 shipments (21.6% of this supplier's total exports)
• MYIT MAHAR TRADING C — $144.7K across 11 shipments (15.9% of this supplier's total exports)
• TO THE ORDER OF NATI — $81.4K across 6 shipments (9.0% of this supplier's total exports)
Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED operates with high shipment frequency (66 shipments) at a per-shipment value of $13.8K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Glimepiride Flows
Once Glimepiride leaves the manufacturing plants of companies like INDOCO REMEDIES LIMITED and IPCA LABORATORIES LIMITED, it travels to 5 destination markets with a combined import value of $76.3M. United States absorbs the largest share at 67.1% ($51.2M), followed by South Africa (4.8%) and Philippines (4.5%).
In United States — the top destination — named importers include EVERSANA LIFE SCIENCE SERVICES, LLC, EVERSANA LIFE SCIENCE SERVICES LLC, AMERISOURCE HEALTH SERVICES.
This geographic spread reflects Glimepiride's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Glimepiride Go? Top Importing Countries & Their Buyers
Trade flow of Glimepiride exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United States
United States ranks as the first-largest destination for Glimepiride imports from India, with a total trade value of $51.2M across 122 shipments — representing a 67.1% share of all Glimepiride exports. The average shipment value of $419.7K is above the global average of $24.2K, indicating high-value procurement contracts or branded formulations. This market is served by 5 tracked buyers.
Named Glimepiride importers in United States: EVERSANA LIFE SCIENCE SERVICES, LLC is the largest buyer, accounting for 2.5% ($1.3M) of this market's total imports.
• EVERSANA LIFE SCIENCE SERVICES, LLC — $1.3M (2.5% of United States's total)
• EVERSANA LIFE SCIENCE SERVICES LLC — $905.2K (1.8% of United States's total)
• AMERISOURCE HEALTH SERVICES — $704.6K (1.4% of United States's total)
Key Insight: United States's per-shipment average of $419.7K (1638% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Glimepiride imports from India.
2South Africa
South Africa ranks as the second-largest destination for Glimepiride imports from India, with a total trade value of $3.7M across 0 shipments — representing a 4.8% share of all Glimepiride exports. The average shipment value of $3.7M is above the global average of $24.2K, indicating high-value procurement contracts or branded formulations.
Key Insight: South Africa's per-shipment average of $3.7M (15051% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
South Africa is a key market for Glimepiride imports from India.
3Philippines
Philippines ranks as the third-largest destination for Glimepiride imports from India, with a total trade value of $3.4M across 68 shipments — representing a 4.5% share of all Glimepiride exports. The average shipment value of $50.1K is above the global average of $24.2K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.
Named Glimepiride importers in Philippines: AJANTA PHARMA PHILIPPINES INC is the largest buyer, accounting for 23.3% ($795.0K) of this market's total imports.
• AJANTA PHARMA PHILIPPINES INC — $795.0K (23.3% of Philippines's total)
• I.E. MEDICA INC. — $574.6K (16.9% of Philippines's total)
• BROWN AND BURK PHILIPPINES INC — $460.0K (13.5% of Philippines's total)
Key Insight: Philippines's per-shipment average of $50.1K (108% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Philippines is a key market for Glimepiride imports from India.
4Japan
Japan ranks as the fourth-largest destination for Glimepiride imports from India, with a total trade value of $2.3M across 28 shipments — representing a 3.0% share of all Glimepiride exports. The average shipment value of $81.5K is above the global average of $24.2K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Glimepiride importers in Japan: MEIJI SEIKA PHARMATECH CO., LTD is the largest buyer, accounting for 36.8% ($840.5K) of this market's total imports.
• MEIJI SEIKA PHARMATECH CO., LTD — $840.5K (36.8% of Japan's total)
• MEIJI SEIKA PHARMATECH CO LIMITED — $818.7K (35.9% of Japan's total)
Key Insight: Japan's per-shipment average of $81.5K (238% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Japan is a key market for Glimepiride imports from India.
5Cyprus
Cyprus ranks as the fifth-largest destination for Glimepiride imports from India, with a total trade value of $1.4M across 0 shipments — representing a 1.8% share of all Glimepiride exports. The average shipment value of $1.4M is above the global average of $24.2K, indicating high-value procurement contracts or branded formulations.
Key Insight: Cyprus's per-shipment average of $1.4M (5731% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Cyprus is a key market for Glimepiride imports from India.
People Also Ask — Glimepiride Supplier & Trade Network
Who are the top suppliers of Glimepiride from India?+
Which companies buy Glimepiride from Indian manufacturers?+
Where does Glimepiride exported from India go?+
What is the market share of the top Glimepiride supplier from India?+
What is the average shipment value for Glimepiride exports from India?+
Is Glimepiride manufactured in India and exported globally?+
Which country imports the most Glimepiride from India?+
Who are the buyers of Glimepiride in South Africa?+
How concentrated is the Glimepiride supplier market in India?+
How do I find verified buyers for Glimepiride in specific countries?+
Glimepiride Trade Network — Key Takeaways
- 1INDOCO REMEDIES LIMITED is India's dominant Glimepiride exporter with a 60.4% market share and $46.0M in total exports — making it the single most important sourcing entity in this market.
- 2The top 242 suppliers collectively account for 74.2% of all tracked Glimepiride exports, with a combined trade value of $76.3M.
- 3United States is the largest destination market, absorbing 67.1% of India's Glimepiride exports ($51.2M). South Africa (4.8%) and Philippines (4.5%) follow.
- 4With 3.2K total shipments averaging $24.2K each, the Glimepiride export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include MSJ LIMITED (UNICORN, R.A. WILLIAMS DISTRI, EVERSANA LIFE SCIENCE SERVICES LLC, AMERISOURCE HEALTH SERVICES — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 1 customers
6 suppliers → 94 countries
Network value: $76.3M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Glimepiride — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Glimepiride.
- 2.Flow Mapping: 242 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 3,159 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 94 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3,159 Verified Shipments
242 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists